Glycolipid intermediates in biosynthesis of group B streptococcal capsular polysaccharide

被引：0

作者：

Deng, LY

Wessels, MR

机构：

来源：

STREPTOCOCCI AND THE HOST | 1997年 / 418卷

关键词：

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

收藏

页码：623 / 625

页数：3

相关论文

共 6 条

[1] BAKER CJ, 1990, INFECT DIS, P742
[2] IMMUNODETERMINANT SPECIFICITY OF HUMAN IMMUNITY TO TYPE-III GROUP-B STREPTOCOCCUS
KASPER, DL
BAKER, CJ
BALTIMORE, RS
CRABB, JH
SCHIFFMAN, G
JENNINGS, HJ
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1979, 149 (02) : 327 - 339
[3] TRANSPOSON MUTAGENESIS OF TYPE-III GROUP-B STREPTOCOCCUS - CORRELATION OF CAPSULE EXPRESSION WITH VIRULENCE
RUBENS, CE
WESSELS, MR
HEGGEN, LM
KASPER, DL
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (20) : 7208 - 7212
[4] IDENTIFICATION OF CPSD, A GENE ESSENTIAL FOR TYPE-III CAPSULE EXPRESSION IN GROUP-B STREPTOCOCCI
RUBENS, CE
HEGGEN, LM
HAFT, RF
WESSELS, MR
[J]. MOLECULAR MICROBIOLOGY, 1993, 8 (05) : 843 - 855
[5] EPIDEMIOLOGY OF GROUP-B STREPTOCOCCAL DISEASE - RISK-FACTORS, PREVENTION STRATEGIES, AND VACCINE DEVELOPMENT
SCHUCHAT, A
WENGER, JD
[J]. EPIDEMIOLOGIC REVIEWS, 1994, 16 (02) : 374 - 402
[6] WESSELS MR, 1987, J BIOL CHEM, V262, P8262